Transfusing Individuals with Asian-type DEL Rh Antigen Antibody levels are important for many aspects of clinical care from evaluating the incompatibility of transfusions and transplants to determining… May 10, 2023
Stabilization of Blood Collection and Use in the United States Since 1997, the biennial National Blood Collection and Utilization Survey (NBCUS) has been collecting data on blood use and collection… May 2, 2023
Individual Risk Assessment Questions for Potential Donors at Higher Risk for HIV In January 2023, the U.S. FDA issued draft guidance recommending individual risk-based assessments for potential donors at higher risk for… April 26, 2023
Randomized Trial Results on Donor Sex and RBC Recipient Mortality Observational studies and systematic reviews have found conflicting results on the association between RBC donor sex and associated transfusion recipient… April 18, 2023
Whole Blood Derived Platelet vs. Apheresis Platelets During the COVID-19 pandemic, the U.S. experienced significant blood product shortages. In 2019, approximately 2.5 million platelet units were collected… April 12, 2023
Seven-Day Platelet Storage and Platelet Count Increments Platelets must be stored at room temperature to preserve function, which makes them susceptible to bacterial contamination. Recently, several countries… April 4, 2023
Prothrombin Complex Concentrate Increases Risk of Thromboembolic Events in Trauma Patients Four-factor prothrombin complex concentrate (4F-PCC) is a lyophilized concentrate of coagulation factors that is commonly used for urgent reversal of… March 29, 2023
FDA Guidance for COVID-19 Convalescent Plasma to Remain in Effect During the public health emergency for COVID-19, the U.S. Food and Drug Administration (FDA) issued guidance for the use of… March 22, 2023
Acute Normovolemic Hemodilution Reduces Transfusions in Patients Undergoing Cardiac Surgery Approximately one to two million cardiac surgery operations are performed worldwide each year accounting for about 80% of all surgical… March 15, 2023
Gene Therapy Phase 3 Study Results for Hemophilia B Hemophilia B is a rare, X-linked bleeding disorder caused by partial or complete deficiency of clotting factor IX. Currently, the… March 8, 2023
